Scienmag
APRIL 30, 2022
Budapest, Hungary – 30 April 2022: A method for delivering genetic material to the body is being tested as a way to repair damaged heart muscle after a heart attack. The ground-breaking research is presented today at Frontiers in CardioVascular Biomedicine 2022, a scientific congress of the European Society of Cardiology (ESC).1 The COVID-19 messenger […].
Clinical Trial Podcast
APRIL 30, 2022
In this episode, we tackle another important aspect of clinical research finance, specifically, coverage analysis for US based clinical trials. At the beginning of any clinical trial, coverage analysis is generally required. The process of performing coverage analysis can be rather overwhelming for someone performing this activity for the first time or not as frequently. .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
APRIL 30, 2022
A new study, being presented at this year’s European Congress on Obesity (ECO) in Maastricht, Netherlands (4-7 May), suggests that children in the UK start consuming free sugars (those added to foods and drinks and those occurring naturally in fruit juices, honey and syrups) at a very young age, and that many toddlers’ sugar intake […].
NY Times
APRIL 30, 2022
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Scienmag
APRIL 30, 2022
Hamilton, ON (April 30, 2022) – High-risk patients who need defibrillators to prevent cardiac arrest can experience fewer complications with a type of device implanted under the skin, a Canadian study has found. Credit: Owen Thomas, Hamilton Health Sciences. Hamilton, ON (April 30, 2022) – High-risk patients who need defibrillators to prevent cardiac arrest can […].
Drug Patent Watch
APRIL 30, 2022
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Romania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Romania? appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
82 
Let's personalize your content